Pentapeptide compounds and uses related thereto
US7423116B2 · kind B2 · utility
27Cited by
42References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 12, 2006 |
| Grant date | Sep 9, 2008 |
| Priority date | — |
| Expiry date | Jul 12, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Pentapeptide compounds are disclosed. The compounds have biological activity, e.g., cytotoxicity. Prodrugs having targeting groups and pentapeptide moieties, as well as precursors thereof are also disclosed. For example, precursors having a reactive linker that can serve as a reaction site for joining to a targeting agent, e.g., an antibody, as disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.